By Kat Greene ( January 23, 2017, 10:58 PM EST) -- Just days after it reached a $100 million deal with the Federal Trade Commission and several states to end allegations it had snapped up a monopoly on infant seizure drug Acthar, Mallinckrodt PLC was hit with a proposed shareholder class action alleging executives had long concealed upcoming trouble....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.